[ORGANIZATION]
Eisai Co.
Featured in 1 tracked story · first seen
Situations
Leqembi Alzheimer’s drug approvals
2 clusters · 2 sources · last updated
Latest: Eisai launches Leqembi in India, introducing first disease-modifying Alzheimer’s treatment
In July 2026 the U.S. Food and Drug Administration cleared a subcutaneous, at‑home starter dose of Leqembi (lecanemab), allowing patients or caregivers to administer the first injection outside a clinic. The approval was